These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28439239)

  • 1. Development of Automated Patch Clamp Technique to Investigate CFTR Chloride Channel Function.
    Billet A; Froux L; Hanrahan JW; Becq F
    Front Pharmacol; 2017; 8():195. PubMed ID: 28439239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for combinations of small-molecule correctors to restore f508del-cystic fibrosis transmembrane conductance regulator function and processing.
    Boinot C; Jollivet Souchet M; Ferru-Clément R; Becq F
    J Pharmacol Exp Ther; 2014 Sep; 350(3):624-34. PubMed ID: 24970923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.
    Cai Z; Palmai-Pallag T; Khuituan P; Mutolo MJ; Boinot C; Liu B; Scott-Ward TS; Callebaut I; Harris A; Sheppard DN
    J Physiol; 2015 Jun; 593(11):2427-46. PubMed ID: 25763566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
    Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusters of Cl- channels in CFTR-expressing Sf9 cells switch spontaneously between slow and fast gating modes.
    Larsen EH; Price EM; Gabriel SE; Stutts MJ; Boucher RC
    Pflugers Arch; 1996 Jul; 432(3):528-37. PubMed ID: 8766014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological evaluation of cystic fibrosis conductance transmembrane regulator (CFTR) expression in human monocytes.
    Ettorre M; Verzè G; Caldrer S; Johansson J; Calcaterra E; Assael BM; Melotti P; Sorio C; Buffelli M
    Biochim Biophys Acta; 2014 Oct; 1840(10):3088-95. PubMed ID: 25046381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel.
    Gené GG; Llobet A; Larriba S; de Semir D; Martínez I; Escalada A; Solsona C; Casals T; Aran JM
    Hum Mutat; 2008 May; 29(5):738-49. PubMed ID: 18306312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
    Arora K; Naren AP
    Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
    Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
    Amico G; Brandas C; Moran O; Baroni D
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
    Yang H; Ma T
    Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of synergistic combinations of F508del cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
    Lin S; Sui J; Cotard S; Fung B; Andersen J; Zhu P; El Messadi N; Lehar J; Lee M; Staunton J
    Assay Drug Dev Technol; 2010 Dec; 8(6):669-84. PubMed ID: 21050065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels.
    Wang F; Zeltwanger S; Hu S; Hwang TC
    J Physiol; 2000 May; 524 Pt 3(Pt 3):637-48. PubMed ID: 10790148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect.
    Robert R; Carlile GW; Pavel C; Liu N; Anjos SM; Liao J; Luo Y; Zhang D; Thomas DY; Hanrahan JW
    Mol Pharmacol; 2008 Feb; 73(2):478-89. PubMed ID: 17975008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pharmacological characterization of the N1303K mutant CFTR.
    DeStefano S; Gees M; Hwang TC
    J Cyst Fibros; 2018 Sep; 17(5):573-581. PubMed ID: 29887518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents.
    Schwiebert EM; Flotte T; Cutting GR; Guggino WB
    Am J Physiol; 1994 May; 266(5 Pt 1):C1464-77. PubMed ID: 7515570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
    Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patch-clamp and planar lipid bilayer techniques: powerful and versatile tools to investigate the CFTR Cl- channel.
    Sheppard DN; Gray MA; Gong X; Sohma Y; Kogan I; Benos DJ; Scott-Ward TS; Chen JH; Li H; Cai Z; Gupta J; Li C; Ramjeesingh M; Berdiev BK; Ismailov II; Bear CE; Hwang TC; Linsdell P; Hug MJ
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():101-8. PubMed ID: 15463939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.